Alps Advisors Inc Haemonetics Corp Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $16,118 - $18,522	-200 Reduced 5.38%	3,520 $300,000
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $307,123 - $347,782	3,720 New	3,720 $333,000
Q3 2020 Nov 04, 2020	SELL	$75.65 - $93.58 $481,814 - $596,011	-6,369 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$84.96 - $118.91 $312,143 - $436,875	3,674 Added 136.33%	6,369 $570,000
Q1 2020 May 06, 2020	BUY	$74.34 - $121.82 $200,346 - $328,304	2,695 New	2,695 $269,000

351

56M

544K

438K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.2B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.